India to Saudi Arabia: Erlotinib Export Trade Route

The India to Saudi Arabia Erlotinib corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $330.7K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's erlotinib manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $165.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 33.0%, placing it at rank #14 among India's top erlotinib export destinations globally.

On the import side, key buyers of Indian erlotinib in Saudi Arabia include TO THE ORDER. TO THE ORDER is the single largest importer with 2 shipments valued at $330.7K USD.

India's erlotinib exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $165.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as erlotinib spc 100mg tablets erlotinib 250 packs x 3x10 s 7500 nos, suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER is the largest importer with 2 shipments worth $330.7K USD — representing 100% of all erlotinib imports from India on this route.